Form Type: 4

SEC EDGAR Link
Accession Number:0001140361-21-021491
Date:2021-06-15
Issuer: PDS BIOTECHNOLOGY CORP (PDSB)
Original Submission Date:

Reporting Person:

VAN VOORHEES SETH
C/O PDS BIOTECHNOLOGY CORPORATION
25B VREELAND ROAD FLORHAM PARK, NJ 07932

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-15 P 17,647 a $8.50 17,647 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 represents shares of common stock purchased by the reporting person at the public offering price in connection with the issuer's firm commitment underwritten public offering of common stock, which closed on june 17, 2021, and such shares of common stock are subject to a lock up agreement between the reporting person and cantor fitzgerald & co., pursuant to which the shares cannot be sold for 90 days following june 15, 2021.
WhaleWisdom Logo

Elevate your investments